Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Abortion kit

Executive Summary

Abortion kit: FDA halts promotion of home abortion and self-sterilization kits marketed through the Internet. The self-sterilization kit uses the unapproved drug quinacrine, and the abortion kit uses an unapproved combination of methotrexate and misoprostol (Searle's Cytotec). In a June 17 "Talk Paper," FDA states that use of the kits without a physician's supervision could lead to heavy vaginal bleeding, abnormal pregnancies and birth defects, permanent damage to reproductive organs and death. Although FDA does not know who is responsible for the products, it has removed promotional materials from the Internet by contacting the Web site's server...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS030398

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel